Stock NCAC NEWT ACQU
Add to a list
To use this feature you must be a member
Log inSign up

Financials NEWT ACQU

Equities

NCAC

KYG6448C1033

Market Closed - Nasdaq
Other stock markets
 21:30:01 31/05/2024 BST 		5-day change 1st Jan Change
0.75 USD +2.04% Intraday chart for NEWT ACQU -9.53% -91.88%
01-25 Newcourt Acquisition Corp(NasdaqGM:NCAC) dropped from NASDAQ Composite Index CI
01-25 Psyence Therapeutics Corp. completed the acquisition of Newcourt Acquisition Corp from Newcourt SPAC Sponsor LLC, Polar Asset Management Partners Inc. and others in a reverse merger transaction. CI

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 323.8 335.9
Enterprise Value (EV) 1 323.2 335.8
P/E ratio - 33.5 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA - -
EV / FCF - 26,560,582 x
FCF Yield - 0%
Price to Book -17.6 x -24.2 x
Nbr of stocks (in thousands) 32,675 32,675
Reference price 2 9.910 10.28
Announcement Date 01/04/22 23/03/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022
Net sales - -
EBITDA - -
EBIT 1 -0.4011 -1.294
Operating Margin - -
Earnings before Tax (EBT) 1 9.877 8.014
Net income 1 9.877 8.014
Net margin - -
EPS - 0.3066
Free Cash Flow - 12.64
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - 157.74%
Dividend per Share - -
Announcement Date 01/04/22 23/03/23
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022
Net Debt 1 - -
Net Cash position 1 0.65 0.13
Leverage (Debt/EBITDA) - -
Free Cash Flow - 12.6
ROE (net income / shareholders' equity) - -49.7%
ROA (Net income/ Total Assets) - -0.31%
Assets 1 - -2,553
Book Value Per Share 2 -0.5600 -0.4300
Cash Flow per Share 2 0.0200 0
Capex - -
Capex / Sales - -
Announcement Date 01/04/22 23/03/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. NCAC Stock
  4. Financials NEWT ACQU